Connect with us
[bsa_pro_ad_space id=12]

Brownstone Institute

How Deadly Is Covid? A Major Study Defies Conventional Wisdom

Published

4 minute read

From the Brownstone Institute

BY WILL JONES

COVID-19 is much less deadly in the non-elderly population than previously thought, a major new study of antibody prevalence surveys has concluded.

The study was led by Dr. John Ioannidis, Professor of Medicine and Epidemiology at Stanford University, who famously sounded an early warning on March 17th, 2020 with a widely-read article in Stat News, presciently arguing that “we are making decisions without reliable data” and “with lockdowns of months, if not years, life largely stops, short-term and long-term consequences are entirely unknown, and billions, not just millions, of lives may be eventually at stake.”

In the new study, which is currently undergoing peer review, Prof. Ioannidis and colleagues found that across 31 national seroprevalence studies in the pre-vaccination era, the average (median) infection fatality rate of COVID-19 was estimated to be just 0.035% for people aged 0-59 years people and 0.095% for those aged 0-69 years.

A further breakdown by age group found that the average IFR (Infection Fatality Rate) was 0.0003% at 0-19 years, 0.003% at 20-29 years, 0.011% at 30-39 years, 0.035% at 40-49 years, 0.129% at 50-59 years, and 0.501% at 60-69 years.

The study states that it shows a “much lower pre-vaccination IFR in non-elderly populations than previously suggested”.

A breakdown by country reveals the wide range of IFR values across different populations.

Infection fatality rate (IFR) and 95% confidence interval per country for people under 70 years old.

The significantly higher values for the top seven suggest some of the difference may be an artifact of, for example, the way Covid deaths are counted, particularly where excess death levels are similar. Note also that the antibody studies date from various points during the first year of the pandemic, most of them prior to the large winter wave of 2020-21, when levels of spread and numbers of deaths were more varied than later in the pandemic as subsequent waves caused countries to converge.

The reason some countries had much lower values and some much higher is not completely clear. The authors suggest that “much of the diversity in IFR across countries is explained by differences in age structure,” as per the plot below.

Meta-regression of IFR as a function of the proportion of the population under 50 years old among those 0-69 years old.

However, the age breakdown by country suggests that the IFR differed for each age group in each country, casting doubt on that suggestion. (In the chart below, note the logarithmic scale, and ignore the zig-zag lines, which are due to small countries having low numbers of deaths.)

IFR in each country per each specified age bin

Why are countries seeing differing IFRs even for the same age groups? The authors suggest a number of explanations, including data artefacts (e.g. if the number of deaths or seroprevalence are not accurately measured), presence and severity of comorbidities (for example, obesity affects 42% of the US population, but the proportion of obese adults is only 2% in Vietnam, 4% in India and under 10% in most African countries, though it affects almost 40% of South African women), the presence of frail individuals in nursing homes and differences in management, health care, overall societal support and levels of drug problems.

Prof. Ioannidis has previously published a number of papers estimating COVID-19’s IFR using seroprevalence surveys. He and his team conclude that their new estimates provide a baseline from which to assess further IFR declines following the widespread use of vaccination, prior infections and evolution of new variants such as Omicron.

Reprinted from DailySceptic

Author

  • Will Jones is editor of the Daily Sceptic.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Brownstone Institute

The WHO: Our New Overlords

Published on

From the Brownstone Institute

BY John Mac GhlionnJOHN MAC GHLIONN

According to its website, the World Health Organization (WHO), a specialized agency of the United Nations, “works worldwide to promote health, keep the world safe, and serve the vulnerable.” In recent times, however, the organization has become a vehicle for corruptiondeceit, and Chinese propaganda.

The WHO is an incredibly powerful organization with 194 member states. When the WHO speaks, the world listens. When the WHO decides on a plan of action, the world changes.

As the piece demonstrates, the WHO has aspirations of becoming even more powerful than it already is. If successful, the consequences could prove to be severe.

Last year, Henry I. Miller, a physician and molecular biologist, wrote a stinging piece that took direct aim at the WHO’s “bungled response to the coronavirus.” Miller, like so many others around the world, was particularly disillusioned about the “misplaced trust” placed in the Chinese Communist Party (CCP). As many readers no doubt recall, the CCP did its very best to conceal the COVID-19 outbreak that originated in Wuhan.

Because of the WHO’s numerous failures, Miller argued persuasively that the United States, whose “funding of UN activities exceeds that of every other country,” should refrain from financing the organization unless an “effective oversight and auditing entity” can be created to oversee operations.

In 2020, shortly after suspending financial support, the Trump administration began initiating a process to withdraw the United States from membership in the WHO. However, upon taking office in January 2021, President Joe Biden quickly reversed that decision and restored funding practices.

A few weeks after Miller’s well-argued piece, Sen. Rick Scott (R-Fla.) introduced a bill designed to prevent the WHO from unilaterally imposing public health restrictions on the United States and violating the country’s national sovereignty. The legislation came after the decision-making body of the WHO, the World Health Assembly, met to discuss a “pandemic treaty.” If introduced, such a treaty would give the WHO far greater control over public health decisions in the United States.

Scott said: “The WHO’s radical ‘pandemic treaty’ is a dangerous globalist overreach. The United States of America must never give more power to the WHO.” He added that the bill would “ensure that public health matters in the country remain in the hands of Americans,” and it needed to be passed immediately. It wasn’t. It should have been.

From Jan. 9–13, clandestine meetings took place in Geneva, Switzerland. Those in attendance discussed the possibility of amending the WHO’s International Health Regulations (IHR). For the uninitiated, the regulations are considered an instrument of international law, a legally binding agreement of basically every country in the world (except Liechtenstein) that calls on members to detect, evaluate, report, and respond to public health emergencies in a coordinated manner.

Michael Nevradakis, a senior reporter for The Defender, warned that if the proposed IHR amendments are made, then WHO members would essentially be stripped of their sovereignty. As Nevradakis previously reported, the IHR framework already allows Dr. Tedros Adhanom Ghebreyesus, the WHO director-general, “to declare a public health emergency in any country, without the consent of that country’s government.” The proposed amendments would give even more power to the director-general.

Francis Boyle, a professor of international law at the University of Illinois, told Nevradakis that the proposed changes could violate international law.

Boyle, a legitimate expert who played a pivotal role in drafting the Biological Weapons Anti-Terrorism Act of 1989, believes we are heading toward “a worldwide totalitarian medical and scientific police state,” which the WHO directly controls. That’s because the IHR regulations “are specifically designed to circumvent national, state and local government authorities when it comes to pandemics, the treatment for pandemics and also including in there, vaccines.”

It’s clear to Boyle that the WHO is preparing to adopt the regulations in May of 2023, just a few months from now.

The brilliant researcher James Roguski also shares Boyle’s concerns. He claims that the WHO is attempting a global power grab by morphing from an advisory organization into what can only be described as a global law-enforcement agency. If introduced, the IHR changes, he suggested, “would institute global digital health certificates, dramatically increase the billions of dollars available to the WHO and enable nations to implement the regulations WITHOUT respect for the dignity, human rights and fundamental freedoms of people.”

Although COVID-19 is now a distant memory for many, another pandemic, we’re told, is just around the corner. When it comes, the WHO may very well be in a position to order you, dear reader, to do exactly what it wants, when it wants. If these amendments are made in May, resistance may prove to be utterly futile.

Reposted from Epoch Times

 

Author

  • John Mac Ghlionn

    With a doctorate in psychosocial studies, John Mac Ghlionn works as both a researcher and essayist. His writing has been published by the likes of Newsweek, NY Post, and The American Conservative. He can be found on Twitter: @ghlionn, and on Gettr: @John_Mac_G

Continue Reading

Brownstone Institute

FOIA Doc Shows BioNTech Founders Postdated Start of C19 Vax Project

Published on

From the Brownstone Institute

BY Robert KogonROBERT KOGON

As noted in my last article on BioNTech’s “brazen” avoidance of safety testing of its Covid-19 vaccine, BioNTech founders Ugur Sahin and Özlem Türeci claim in their book The Vaccine that the company’s Covid-19 vaccine project got underway on January 27, 2020. But documentary evidence released in response to a FOIA request (and included in the so-called “Pfizer documents”) shows that this is not true and that the company had in fact already begun preclinical, i.e. animal, testing nearly two weeks earlier, on January 14.

BioNTech R&D STUDY REPORT No. R-20-0072 is available here. The report is also referenced and discussed in an FDA submission on the preclinical study program that is available here. The below screenshot shows the study dates from p. 8 of the report.

In the book, Sahin claims furthermore that he only even became interested in the outbreak in Wuhan on January 24, after reading an article in the German weekly Der Spiegel (p. 4) and/or a submission to The Lancet (p. 6). But look again at the study dates above. BioNTech had already completed the first preclinical study for its Covid-19 vaccine the day before!

January 24, 2020 was a Friday. On Sahin’s account, he took the decision to launch his Covid-19 vaccine project over the weekend and unveiled his plans to his collaborators at BioNTech’s headquarters in Mainz, Germany on the following Monday: January 27 (ch. 2 passim and p. 42; see screencap below).

Sahin claims (p. 33) that it was at this January 27 meeting that he asked BioNTech’s animal testing team to prepare the preclinical program that was in fact already underway!

It should be noted that January 14, 2020, the start-date of the first preclinical study, was just two weeks after the first report of Covid-19 cases in Wuhan and just a day after the release of the full SARS-CoV-2 genome (drafts had been released previously).

BioNTech’s first preclinical study was evidently prepared before publication of the genome and in anticipation of it. As explained in the summary of the study (p. 6), its purpose was to test BioNTech mRNA formulated in lipid nanoparticles produced by the Canadian firm Acuitas. But the mRNA was here encoding a proxy antigen (luciferase), not the spike protein of SARS-CoV-2 that would later serve as the target antigen.

The study looked at both biodistribution and immune system activation. As the FDA submission on the preclinical program puts it, “Platform properties that support BNT162b2 were initially demonstrated with non-SARS-CoV-2 antigens” (2.4 NONCLINICAL OVERVIEW, p. 7).

In The Vaccine, which was written with the journalist Joe Miller, Sahin and Türeci talk about the need to obtain the Acuitas lipids, which, they say, were more suitable for intramuscular injection than BioNTech’s own in-house lipids. But, again, they postdate the matter. Thus, on p. 52, we read: “The missing piece was still Acuitas, who had not yet consented to the use of their lipids. Then, on the morning of Monday 3 February, [Acuitas CEO] Tom Madden offered his help.” But BioNTech was already running tests using the Acuitas lipids three weeks earlier!

Furthermore, BioNTech was not able to formulate its mRNA into the lipids itself, but depended on the Austrian company Polymun to do this for it. As noted in The Vaccine (p.51), Polymun’s facilities are an 8-hour drive from BioNTech’s headquarters in Mainz. In the book, Sahin and Türeci describe the first batch of mRNA for the vaccine tests proper being packed up and driven by car to Polymun outside Vienna: “A couple of days later, a small Styrofoam box containing frozen vials full of vaccine would be driven back over the border to BioNTech” (pp. 116-117).

But presumably this same back-and-forth had to have occurred with the mRNA encoding the luciferase. This means that as a practical matter “Project Lightspeed” must have gotten underway even earlier: at least several days before the January 14 start date of the study.

Why did Sahin and Türeci postdate the launch of their Covid-19 vaccine project in their book? Well, undoubtedly because the actual start date – and we do not know when exactly the actual start date was – would have seemed far too soon. Based on the above considerations, it must have been at the latest just days after the first December 31, 2019 report of Covid-19 cases in Wuhan.

Author

  • Robert Kogon

    Robert Kogon is a pen name for a widely-published financial journalist, a translator, and researcher working in Europe. Follow him at Twitter here. He writes at edv1694.substack.com.

Continue Reading

Trending

X